Clinical Trial Update: Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

View source ↗

Summary

This PMCF update reports the completed post-market clinical follow-up of the Coroflex ISAR NEO stent in all-comers with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Coroflex ISAR NEO

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Coronary Artery Disease | Status: COMPLETED